Sonidegib Completed Phase 2 Trials for Gorlin's Syndrome / Nevoid Basal Cell Carcinoma Syndrome / Carcinoma, Basal Cell (BCC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01350115Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)